Richard Schwartz

No open positions remaining

Health Technology

Consumer Services

Finance

Profile

Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.

Former positions of Richard Schwartz

Companies	Position	End
CRISPR THERAPEUTICS AG	Chief Tech/Sci/R&D Officer	01/10/2019
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines	Corporate Officer/Principal	01/05/2008
Vaccine Research Center	Corporate Officer/Principal	-
VAXART, INC.	Chief Tech/Sci/R&D Officer	-
SYNLOGIC, INC.	Corporate Officer/Principal	-

See the detail of Richard Schwartz's experience

Training of Richard Schwartz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Schwartz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines	Health Technology
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vaccine Research Center
CRISPR Therapeutics AG CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines	Health Technology
Synlogic, Inc. Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company	Finance
Vaxart, Inc. Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines	Health Technology